Dr. William Fahl, PhD

Board Chairman

Chief Scientific Officer

Co-Founder

Inventor of PrC-210 and other breakthrough compounds protecting cancer patients from side effects of radiation and chemotherapy; multiple patents filed.

Science validated globally through over 110 peer-reviewed publications and numerous significant research grants awarded during his academic career.

Recognized authority in radiation protection, oncology, and pharmacology, and with decades of innovation in drug discovery.

Professor of Oncology, McArdle Laboratory for Cancer Research at the University of Wisconsin Carbone Cancer Center; former Associate Professor of Pharmacology, Northwestern University Medical School, Chicago.

Academic foundation: PhD in Oncology and degree in Zoology, University of Wisconsin.

Co-founder, co-owner, Chairman of the Board, and major shareholder, combining scientific authority with ownership alignment.